Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for follow-up/evaluation of Type I Gastric Neuroendocrine Tumor (g-NET). History significant for chronic atrophic gastritis and hypergastrinemia. Patient reports [asymptomatic / epigastric discomfort / dyspepsia / iron deficiency anemia]. Current medications include [PPIs / H2 blockers]. No history of MEN1 syndrome or Zollinger-Ellison syndrome.
Clinical Examination Findings
General: Patient appears [well-developed / in no acute distress]. Abdomen: Soft, non-tender, non-distended. No palpable masses or organomegaly. Bowel sounds present. EGD findings: [Multiple/Solitary] small (<1cm) polypoid lesions identified in the gastric fundus/body. Mucosa shows signs of atrophic gastritis. Biopsy confirmed well-differentiated neuroendocrine tumor (Grade 1).
Treatment Protocol
Plan: 1. Surveillance EGD with biopsy every [6-12] months. 2. Endoscopic resection (polypectomy) for lesions >1cm or symptomatic lesions. 3. Consider somatostatin analogs (e.g., octreotide) if hypergastrinemia is severe or lesions persist. 4. Monitor serum gastrin and chromogranin A levels. 5. Referral to gastroenterology for ongoing management of underlying atrophic gastritis.